White label ELPA - ClinicalTrials.eu

Study of Obexelimab for Patients with Warm Autoimmune Hemolytic Anemia

Not recruiting

3 1
Investigated Diseases:
- Warm autoimmune haemolytic anaemia
Investigated Drugs:
- Obexelimab
Study on the Effectiveness of Co-Trimoxazole for Treating Ventilator-Associated Pneumonia in ICU Patients Compared to a Drug Combination

Not recruiting

3 1 1 1
Investigated Diseases:
- Pneumonia
Investigated Drugs:
Study on Linsitinib for Patients with Active, Moderate to Severe Thyroid Eye Disease

Not recruiting

2 1
Investigated Diseases:
- Endocrine ophthalmopathy
Investigated Drugs:
- Linsitinib
Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Not recruiting

4 1 1
Investigated Diseases:
- Endometrial cancer
Investigated Drugs:
+9
Study on Alpelisib and Fulvestrant or Ribociclib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer with PIK3CA Mutations

Not recruiting

2 1 1 1
Investigated Diseases:
- Breast cancer metastatic
Investigated Drugs:
Study on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Dystrophy After Cataract Surgery

Not recruiting

3 1
Investigated Diseases:
- Corneal dystrophy
Investigated Drugs:
- Ripasudil
Study on the Safety and Effects of Crovalimab for Treating Vaso-Occlusive Episodes in Sickle Cell Disease Patients

Not recruiting

1 1
Investigated Diseases:
- Sickle cell anaemia with crisis
- Sickle cell disease
Investigated Drugs:
- Crovalimab
Study of SLN124 for Patients with Polycythemia Vera

Not recruiting

1 1
Investigated Drugs:
- Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Tmprss6 Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
Study on the Effect of Ivonescimab, Pemetrexed, and Carboplatin in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutation After Previous Treatment

Not recruiting

3 1 1
Investigated Drugs:
Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Not recruiting

3 1 1 1
Investigated Drugs:
- Vibostolimab
- Pembrolizumab
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies